Significantly, LMP1 plays a key role in the reprogramming of EBV-mediated glycolysis in NPC cells, and anti-glycolytic therapy can effectively enhance the sensitivity of LMP1-overexpressing NPC cells to radiation. Here, PDLIM7 is linked to nasopharyngeal carcinoma.